Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Dr. Seper Dezfoli defined that long-term acid reflux disease — additionally known as gastroesophageal reflux illness (GERD) — is the strongest threat issue...
Dr. Jared Weiss highlights promising methods, together with JNJ-1900, to enhance outcomes for sufferers with stage 3 lung most cancers amid rising early-stage...
